Weibao Wu - Roseville MN, US Anand A. Kekre - Pune, IN Gang Lin - Plymouth MN, US
Assignee:
VERITAS Operating Corporation - Cupertino CA
International Classification:
G06F 12/16
US Classification:
711162, 707204
Abstract:
Various embodiments of systems and methods for performing volume-based incremental backups are disclosed. A method may involve generating a snappoint of a volume. The snappoint indicates which portions (e. g. , blocks or extents) of the volume have been modified between a time at which the snappoint was generated and a time at which a subsequent snappoint was generated. The method may also involve accessing information mapping the file to the volume and, if the snappoint identifies as having been modified any blocks of the volume to which the file maps, copying those blocks from the subsequent snappoint to the backup device. Portions not identified as having been modified by the snappoint are not copied. Program instructions implementing such a method may be stored on a computer accessible medium.
Treating An Inflammatory Disorder Or Inhibiting Respiratory Burst In Adherent Neutrophils With Chemical Inhibitors Of Neutrophil Activation
Hyunsil Han - New York NY, US Gang Lin - New York NY, US Carl Nathan - Larchmont NY, US
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
International Classification:
A61K 31/4709 A61K 31/41 A61P 37/00
US Classification:
514396, 514403, 514468
Abstract:
The present invention relates to a method of treating an inflammatory disorder in a subject with an effective amount of compound having the general formula (I) as described in the present application, under conditions effective to treat the inflammatory disorder. The present invention also relates to a method of inhibiting respiratory burst in neutrophils without inhibiting degranulation in or bacterial killing by the neutrophils by contacting neutrophils with the compounds described above.
Proteasome Inhibitors And Their Use In Treating Pathogen Infection And Cancer
The present invention relates to proteasome inhibitors and their use in methods of treating a subject for a pathogen infection or cancer. The methods involve administering to the subject a compound of Formula (I). (I) where: Q is Formula or Formula, where the crossing dashed line illustrates the bond formed joining Q to the rest of the compound of Formula (I). The remainder of substituents of the compound of Formula (I) are defined in the present application.